Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

Huang, YW; Hsu, CW; Lu, SN; Yu, ML; Su, CW; Su, WW; Chien, RN; Hsu, CS; Hsu, SJ; Lai, HC; Qin, A; Tseng, KC; Chen, PJ

Chen, PJ (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, 7 Chung Shan South Rd, Taipei, Taiwan.; Chen, PJ (corresponding author), Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan.

HEPATOLOGY INTERNATIONAL, 2020; 14 (6): 997